Reducing Peritoneal Carcinomatosis with Phospholipids in Rats
Author Information
Author(s): Otto Jens, Jansen Petra Lynen, Lucas Stefan, Schumpelick Volker, Jansen Marc
Primary Institution: Department of Surgery, University Clinic RWTH Aachen
Hypothesis
Can intraperitoneal administration of phospholipids reduce peritoneal carcinomatosis in rats?
Conclusion
Intraperitoneal application of phospholipids significantly reduced the extent of peritoneal carcinomatosis in rats, especially when tumor cell concentrations were low.
Supporting Evidence
- Phospholipids significantly reduced tumor volume in both experimental settings.
- The area of tumor adhesion was significantly lower in the phospholipid treatment groups compared to controls.
- The Peritoneal Cancer Index was significantly reduced in all treatment groups compared to controls.
Takeaway
This study shows that giving phospholipids inside the belly can help stop cancer cells from sticking and spreading after surgery.
Methodology
The study involved injecting tumor cells and phospholipids into the peritoneal cavity of female BD-IX rats and measuring tumor volume, adhesion area, and Peritoneal Cancer Index after 30 days.
Potential Biases
Potential bias in the evaluation of results due to the lack of blinding in the treatment administration.
Limitations
The study was conducted in a rat model, which may not fully replicate human responses, and the results may not be generalizable to all types of gastrointestinal cancers.
Participant Demographics
Female BD-IX rats, mean body weight 200 g +/- 10 g.
Statistical Information
P-Value
p = 0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website